Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46


Induction of resident memory T cells enhances the efficacy of cancer vaccine.

Nizard M, Roussel H, Diniz MO, Karaki S, Tran T, Voron T, Dransart E, Sandoval F, Riquet M, Rance B, Marcheteau E, Fabre E, Mandavit M, Terme M, Blanc C, Escudie JB, Gibault L, Barthes FLP, Granier C, Ferreira LCS, Badoual C, Johannes L, Tartour E.

Nat Commun. 2017 May 24;8:15221. doi: 10.1038/ncomms15221.


Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects.

Pernot S, Badoual C, Terme M, Castan F, Cazes A, Bouche O, Bennouna J, Francois E, Ghiringhelli F, De La Fouchardiere C, Samalin E, Bachet JB, Borg C, Ducreux M, Marcheteau E, Stanbury T, Gourgou S, Malka D, Taieb J.

Eur J Cancer. 2017 Jul;79:15-22. doi: 10.1016/j.ejca.2017.03.036. Epub 2017 Apr 26.


Immunomodulatory Activity of VEGF in Cancer.

Lapeyre-Prost A, Terme M, Pernot S, Pointet AL, Voron T, Tartour E, Taieb J.

Int Rev Cell Mol Biol. 2017;330:295-342. doi: 10.1016/bs.ircmb.2016.09.007. Epub 2016 Dec 26. Review.


[Immune system and tumors].

Terme M, Tanchot C.

Ann Pathol. 2017 Feb;37(1):11-17. doi: 10.1016/j.annpat.2016.12.004. Epub 2017 Jan 31. French.


IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.

Desbois M, Le Vu P, Coutzac C, Marcheteau E, Béal C, Terme M, Gey A, Morisseau S, Teppaz G, Boselli L, Jacques Y, Béchard D, Tartour E, Cassard L, Chaput N.

J Immunol. 2016 Jul 1;197(1):168-78. doi: 10.4049/jimmunol.1600019. Epub 2016 May 23.


Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.

Fleurence J, Cochonneau D, Fougeray S, Oliver L, Geraldo F, Terme M, Dorvillius M, Loussouarn D, Vallette F, Paris F, Birklé S.

Oncotarget. 2016 Jul 5;7(27):41172-41185. doi: 10.18632/oncotarget.9226.


[Impact of VEGF-A in exhaustion of intratumoral T cells].

Voron T, Tartour É, Taieb J, Terme M.

Med Sci (Paris). 2015 May;31(5):473-5. doi: 10.1051/medsci/20153105004. Epub 2015 Jun 9. French. No abstract available.


VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.

Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet AL, Latreche S, Bergaya S, Benhamouda N, Tanchot C, Stockmann C, Combe P, Berger A, Zinzindohoue F, Yagita H, Tartour E, Taieb J, Terme M.

J Exp Med. 2015 Feb 9;212(2):139-48. doi: 10.1084/jem.20140559. Epub 2015 Jan 19.


Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients.

Gey A, Tadie JM, Caumont-Prim A, Hauw-Berlemont C, Cynober L, Fagon JY, Terme M, Diehl JL, Delclaux C, Tartour E.

Clin Exp Immunol. 2015 May;180(2):280-8. doi: 10.1111/cei.12567.


Colorectal cancer and immunity: what we know and perspectives.

Pernot S, Terme M, Voron T, Colussi O, Marcheteau E, Tartour E, Taieb J.

World J Gastroenterol. 2014 Apr 14;20(14):3738-50. doi: 10.3748/wjg.v20.i14.3738. Review.


Control of the immune response by pro-angiogenic factors.

Voron T, Marcheteau E, Pernot S, Colussi O, Tartour E, Taieb J, Terme M.

Front Oncol. 2014 Apr 2;4:70. doi: 10.3389/fonc.2014.00070. eCollection 2014. Review.


Control of the adaptive immune response by tumor vasculature.

Mauge L, Terme M, Tartour E, Helley D.

Front Oncol. 2014 Mar 28;4:61. doi: 10.3389/fonc.2014.00061. eCollection 2014. Review.


Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia.

Terme M, Dorvillius M, Cochonneau D, Chaumette T, Xiao W, Diccianni MB, Barbet J, Yu AL, Paris F, Sorkin LS, Birklé S.

PLoS One. 2014 Feb 10;9(2):e87210. doi: 10.1371/journal.pone.0087210. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e103395.


VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer.

Terme M, Tartour E, Taieb J.

Oncoimmunology. 2013 Aug 1;2(8):e25156. Epub 2013 Jun 10.


Inhibition of the differentiation of monocyte-derived dendritic cells by human gingival fibroblasts.

Séguier S, Tartour E, Guérin C, Couty L, Lemitre M, Lallement L, Folliguet M, El Naderi S, Terme M, Badoual C, Lafont A, Coulomb B.

PLoS One. 2013 Aug 2;8(8):e70937. doi: 10.1371/journal.pone.0070937. Print 2013.


Immunity and squamous cell carcinoma of the anus: epidemiological, clinical and therapeutic aspects.

Pernot S, Terme M, Zaanan A, Tartour E, Weiss L, Taieb J.

Clin Res Hepatol Gastroenterol. 2014 Feb;38(1):18-23. doi: 10.1016/j.clinre.2013.07.002. Epub 2013 Aug 8. Review.


Immunotherapy of HPV-associated head and neck cancer: Critical parameters.

Nizard M, Sandoval F, Badoual C, Pere H, Terme M, Hans S, Benhamouda N, Granier C, Brasnu D, Tartour E.

Oncoimmunology. 2013 Jun 1;2(6):e24534. Epub 2013 Apr 16.


β2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells.

Hervé J, Dubreil L, Tardif V, Terme M, Pogu S, Anegon I, Rozec B, Gauthier C, Bach JM, Blancou P.

J Immunol. 2013 Apr 1;190(7):3163-71. doi: 10.4049/jimmunol.1201391. Epub 2013 Feb 18.


Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors.

Sandoval F, Terme M, Nizard M, Badoual C, Bureau MF, Freyburger L, Clement O, Marcheteau E, Gey A, Fraisse G, Bouguin C, Merillon N, Dransart E, Tran T, Quintin-Colonna F, Autret G, Thiebaud M, Suleman M, Riffault S, Wu TC, Launay O, Danel C, Taieb J, Richardson J, Zitvogel L, Fridman WH, Johannes L, Tartour E.

Sci Transl Med. 2013 Feb 13;5(172):172ra20. doi: 10.1126/scitranslmed.3004888. Erratum in: Sci Transl Med. 2013 Mar 27;5(178):178er2. Suleman, Muhammed [corrected to Suleman, Muhammad].


Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo.

Cochonneau D, Terme M, Michaud A, Dorvillius M, Gautier N, Frikeche J, Alvarez-Rueda N, Bougras G, Aubry J, Paris F, Birklé S.

Cancer Lett. 2013 Jun 10;333(2):194-204. doi: 10.1016/j.canlet.2013.01.032. Epub 2013 Jan 28.


NK cells from pleural effusions are potent antitumor effector cells.

Terme M, Fridman WH, Tartour E.

Eur J Immunol. 2013 Feb;43(2):331-4. doi: 10.1002/eji.201243264.


Modulation of immunity by antiangiogenic molecules in cancer.

Terme M, Colussi O, Marcheteau E, Tanchot C, Tartour E, Taieb J.

Clin Dev Immunol. 2012;2012:492920. doi: 10.1155/2012/492920. Epub 2012 Dec 24. Review.


VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer.

Terme M, Pernot S, Marcheteau E, Sandoval F, Benhamouda N, Colussi O, Dubreuil O, Carpentier AF, Tartour E, Taieb J.

Cancer Res. 2013 Jan 15;73(2):539-49. doi: 10.1158/0008-5472.CAN-12-2325. Epub 2012 Oct 29.


Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.

Tanchot C, Terme M, Pere H, Tran T, Benhamouda N, Strioga M, Banissi C, Galluzzi L, Kroemer G, Tartour E.

Cancer Microenviron. 2013 Aug;6(2):147-57. doi: 10.1007/s12307-012-0122-y. Epub 2012 Oct 27.


Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

Pere H, Tanchot C, Bayry J, Terme M, Taieb J, Badoual C, Adotevi O, Merillon N, Marcheteau E, Quillien VR, Banissi C, Carpentier A, Sandoval F, Nizard M, Quintin-Colonna F, Kroemer G, Fridman WH, Zitvogel L, Oudard SP, Tartour E.

Oncoimmunology. 2012 May 1;1(3):326-333.


Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells.

Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, Chen L, Mécheri S, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Degli-Esposti M, Chaput N, Zitvogel L.

Cancer Res. 2012 Jun 1;72(11):2757-67. doi: 10.1158/0008-5472.CAN-11-3379. Epub 2012 Mar 16.


IL-18 induces PD-1-dependent immunosuppression in cancer.

Terme M, Ullrich E, Aymeric L, Meinhardt K, Desbois M, Delahaye N, Viaud S, Ryffel B, Yagita H, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Chaput N, Zitvogel L.

Cancer Res. 2011 Aug 15;71(16):5393-9. doi: 10.1158/0008-5472.CAN-11-0993. Epub 2011 Jul 1.


Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.

Tartour E, Pere H, Maillere B, Terme M, Merillon N, Taieb J, Sandoval F, Quintin-Colonna F, Lacerda K, Karadimou A, Badoual C, Tedgui A, Fridman WH, Oudard S.

Cancer Metastasis Rev. 2011 Mar;30(1):83-95. doi: 10.1007/s10555-011-9281-4. Review.


Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.

Conforti R, Ma Y, Morel Y, Paturel C, Terme M, Viaud S, Ryffel B, Ferrantini M, Uppaluri R, Schreiber R, Combadière C, Chaput N, André F, Kroemer G, Zitvogel L.

Cancer Res. 2010 Jan 15;70(2):490-500. doi: 10.1158/0008-5472.CAN-09-1890. Epub 2010 Jan 12.


The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.

Terme M, Mignot G, Ullrich E, Bonmort M, Minard-Colin V, Jacquet A, Schultze JL, Kroemer G, Leclerc C, Chaput N, Zitvogel L.

Cancer Res. 2009 Aug 15;69(16):6590-7. doi: 10.1158/0008-5472.CAN-08-4473.


Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.

Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N.

PLoS One. 2009;4(3):e4942. doi: 10.1371/journal.pone.0004942. Epub 2009 Mar 25.


Natural killer cell-directed therapies: moving from unexpected results to successful strategies.

Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L.

Nat Immunol. 2008 May;9(5):486-94. doi: 10.1038/ni1580. Review.


Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells.

Terme M, Chaput N, Combadiere B, Ma A, Ohteki T, Zitvogel L.

J Immunol. 2008 Apr 1;180(7):4679-86.


Dendritic cells and innate defense against tumor cells.

Ullrich E, Ménard C, Flament C, Terme M, Mignot G, Bonmort M, Plumas J, Chaperot L, Chaput N, Zitvogel L.

Cytokine Growth Factor Rev. 2008 Feb;19(1):79-92. Epub 2007 Dec 26. Review.


Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines.

Taieb J, Chaput N, Schartz N, Roux S, Novault S, Ménard C, Ghiringhelli F, Terme M, Carpentier AF, Darrasse-Jèze G, Lemonnier F, Zitvogel L.

J Immunol. 2006 Mar 1;176(5):2722-9. Erratum in: J Immunol. 2006 Aug 1;177(3):2024. Darrasse-Jèse, Guillaume [corrected to Darrasse-Jèze, Guillaume].


A novel dendritic cell subset involved in tumor immunosurveillance.

Taieb J, Chaput N, Ménard C, Apetoh L, Ullrich E, Bonmort M, Péquignot M, Casares N, Terme M, Flament C, Opolon P, Lecluse Y, Métivier D, Tomasello E, Vivier E, Ghiringhelli F, Martin F, Klatzmann D, Poynard T, Tursz T, Raposo G, Yagita H, Ryffel B, Kroemer G, Zitvogel L.

Nat Med. 2006 Feb;12(2):214-9. Epub 2006 Jan 29.


Dendritic cell-NK cell cross-talk: regulation and physiopathology.

Zitvogel L, Terme M, Borg C, Trinchieri G.

Curr Top Microbiol Immunol. 2006;298:157-74. Review.


CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.

Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L.

J Exp Med. 2005 Oct 17;202(8):1075-85.


IL-2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes.

Schartz NE, Chaput N, Taieb J, Bonnaventure P, Trébeden-Nègre H, Terme M, Ménard C, Lebbé C, Schimpl A, Ardouin P, Zitvogel L.

Eur J Immunol. 2005 Oct;35(10):2840-50.


BCR/ABL promotes dendritic cell-mediated natural killer cell activation.

Terme M, Borg C, Guilhot F, Masurier C, Flament C, Wagner EF, Caillat-Zucman S, Bernheim A, Turhan AG, Caignard A, Zitvogel L.

Cancer Res. 2005 Jul 15;65(14):6409-17.


Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects.

Borg C, Terme M, Taïeb J, Ménard C, Flament C, Robert C, Maruyama K, Wakasugi H, Angevin E, Thielemans K, Le Cesne A, Chung-Scott V, Lazar V, Tchou I, Crépineau F, Lemoine F, Bernard J, Fletcher JA, Turhan A, Blay JY, Spatz A, Emile JF, Heinrich MC, Mécheri S, Tursz T, Zitvogel L.

J Clin Invest. 2004 Aug;114(3):379-88.


IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.

Terme M, Tomasello E, Maruyama K, Crépineau F, Chaput N, Flament C, Marolleau JP, Angevin E, Wagner EF, Salomon B, Lemonnier FA, Wakasugi H, Colonna M, Vivier E, Zitvogel L.

J Immunol. 2004 May 15;172(10):5957-66.


Imatinib mesylate impairs Flt3L-mediated dendritic cell expansion and antitumor effects in vivo.

Taïeb J, Maruyama K, Borg C, Terme M, Zitvogel L.

Blood. 2004 Mar 1;103(5):1966-7; author reply 1967. No abstract available.


[NK cell-based immunotherapy: new prospects and involvement of dendritic cells].

Borg C, Taieb J, Terme M, Maruyama K, Flament C, Angevin E, Zitvogel L.

Bull Cancer. 2003 Aug-Sep;90(8-9):699-705. Review. French.


Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.

Ikarashi Y, Mikami R, Bendelac A, Terme M, Chaput N, Terada M, Tursz T, Angevin E, Lemonnier FA, Wakasugi H, Zitvogel L.

J Exp Med. 2001 Oct 15;194(8):1179-86. Erratum in: J Exp Med 2001 Nov 5;194(9):1391.


[Role of dendritic cells in the modulation of innate effectors of immunity].

Terme M, Masurier C, Fernandez N, Lacassagne MN, Marolleau JP, Zitvogel L.

Pathol Biol (Paris). 2001 Jul;49(6):475-7. Review. French.


Supplemental Content

Support Center